Direct Detection of Glutathione Conjugates in Human Liver Microsomes Using ACQUIT Y UPLC I-Class, Xevo G2-S QTof, and UNIFI

Significance of Topic

The detection of reactive drug metabolites is critical in pharmaceutical safety assessment to prevent clinical toxicity associated with protein haptenization.
Trapping reactive intermediates with glutathione (GSH) enables identification of potentially harmful metabolites early in drug development.
High-resolution mass spectrometry combined with advanced data processing offers improved sensitivity and confidence in detecting GSH conjugates.

Study Objectives and Overview

This work demonstrates a generic workflow to simultaneously detect parent drug, phase I metabolites, and GSH conjugates in human liver microsomal incubations.
Clozapine serves as a model compound to illustrate the formation pathways of nitrenium intermediates and their trapping by GSH.
The study tracks metabolite formation over a two-hour incubation under three conditions: without GSH, with GSH, and with GSH plus cytosol.

Methodology and Used Instrumentation

Liquid chromatography was performed on an ACQUITY UPLC I-Class system using a BEH C18 column (2.1×100 mm, 1.7 µm) at 60 °C with a 10 min gradient.
Mass spectrometric analysis employed a Xevo G2-S QTof with positive electrospray ionization and MSᴱ data acquisition (low CE 2 eV, high CE ramp 10–30 eV).
Data were processed in UNIFI Scientific Information System using automatic charge state deconvolution and GSH trapping reagent specification.

Results and Discussion

In GSH-containing incubations, twelve metabolites were observed: six phase I derivatives and six GSH adducts.
Phase I metabolites predominantly appeared as singly charged ions, whereas GSH adducts were exclusively detected as doubly charged species.
Charge state summarization in UNIFI ensured reliable grouping of multiple ion forms, avoiding false negatives under ESI+ conditions.
Extracted ion chromatograms revealed major adduct peaks at retention time ~2.1 min, with minor isomers of identical mass.
Trend plots across time points showed parent clozapine decline and concurrent rise of phase I and phase II species, with ~40% conversion at 90 min.

Benefits and Practical Applications

The combined UPLC–MSᴱ approach provides a streamlined workflow for comprehensive metabolite profiling including reactive conjugates.
Automated deconvolution enhances detection sensitivity for multiply charged adducts, facilitating rapid interpretation.
This method supports risk assessment by enabling early identification of reactive metabolites in drug discovery.

Future Trends and Potential Applications

Advances in high-resolution MS and data-driven software will enable more extensive screening of diverse trapping reagents beyond GSH.
Integration with isotope-labeling strategies and machine-learning algorithms may further improve detection of low-abundance reactive species.
Broader application of this workflow to cell-based and in vivo models can enhance translational relevance for safety evaluation.

Conclusion

A generic MSᴱ method using ACQUITY UPLC I-Class, Xevo G2-S QTof, and UNIFI enables direct detection of GSH conjugates alongside parent and phase I metabolites.
Automatic charge deconvolution is essential for capturing multiply charged adducts under positive ionization.
This streamlined platform offers robust, high-throughput capability for reactive metabolite screening in pharmaceutical research.

Reference

• Ma L et al. Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and post acquisition data mining. Chem Res Toxicol. 2008;21(8):1477–1483.
• Zhu X et al. Enhanced screening of glutathione-trapped reactive metabolites by in-source collision-induced dissociation and extraction of product ion using UHPLC-high resolution mass spectrometry. Anal Chem. 2011;83(22):9516–9523.
• Liao S et al. High-throughput screening for glutathione conjugates using stable-isotope labeling and negative electrospray ionization precursor-ion mass spectrometry. Rapid Commun Mass Spectrom. 2012;26(6):659–669.
• Ma S, Chowdhury SK. Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS. Bioanalysis. 2013;5(11):1285–1297.
• Williams DP et al. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J Pharmacol Exp Ther. 1997;283(3):1375–1382.
• Rea V et al. Role of residue 87 in the activity and regioselectivity of clozapine metabolism by drug-metabolizing CYP102A1 M11H: application for structural characterization of clozapine GSH conjugates. Drug Metab Dispos. 2011;39(12):2411–2420.